Martin H. Huber Jr. - Insider Trading & Ownership

Entity
Individual
Location
C/O Tesaro, Inc., 1000 Winter Street, Suite 3300, Waltham, MA
Summary
The estimated net worth of Martin H. Huber Jr. is at least $2.2M dollars as of September 13, 2024. Martin H. Huber Jr. is the President, CEO, Director of Mersana Therapeutics, Inc. and owns shares of Mersana Therapeutics, Inc. (MRSN) stock worth about $1.31M. Martin H. Huber Jr. is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $895K.
All Insider Reports
All Insider Reports

Ownership of Martin H. Huber Jr.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRSN Mersana Therapeutics, Inc. President, CEO, Director $1.31M -$88.7K -6.37% Sep 11, 2024
SNDX Syndax Pharmaceuticals Inc Director $895K Feb 7, 2024
XLO Xilio Therapeutics, Inc. President And Head Of R&D Aug 16, 2023

Insider Transactions Reported by Martin H. Huber Jr.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.